Heart transplant recipient patient with COVID‐19 treated with tocilizumab. Issue 6 (10th July 2020)

• Record Type: Journal Article
• Authors: Mattioli, Massimo; Fustini, Elisa; Gennarini, Silvia
• Is Part Of: Transplant infectious disease. Volume 22:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-07-10
• Subjects: COVID‐19 -- heart transplant -- pneumonia -- tocilizumab; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.13380
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: A heart transplant 62‐year‐old patient referred for coronavirus‐19 disease (COVID‐19) pneumonia. At admission, he was febrile, tachypnoeic, and mild hypoxic with dry cough; during hospitalization, a diffuse morbilliform skin rash appeared. He was treated with tocilizumab with symptoms improvement, without a complete pulmonary function recovery. Skin rash, highly suggestive for COVID‐19 cutaneous involvement, persisted for ten days despite tocilizumab administration.